These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 27236554)

  • 1. Therapeutic Antibodies in Cancer Therapy.
    Gasser M; Waaga-Gasser AM
    Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody therapeutics in cancer.
    Sliwkowski MX; Mellman I
    Science; 2013 Sep; 341(6151):1192-8. PubMed ID: 24031011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.
    Philips GK; Atkins M
    Int Immunol; 2015 Jan; 27(1):39-46. PubMed ID: 25323844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the art in anti-cancer mAbs.
    Chiavenna SM; Jaworski JP; Vendrell A
    J Biomed Sci; 2017 Feb; 24(1):15. PubMed ID: 28219375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors.
    Chester C; Marabelle A; Houot R; Kohrt HE
    Curr Opin Immunol; 2015 Apr; 33():1-8. PubMed ID: 25576932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in gastrointestinal cancers.
    Bronte G; Cicero G; Cusenza S; Galvano A; Musso E; Rizzo S; Sortino G; Roselli M; Bazan V; Fiorentino E; Russo A
    Expert Opin Biol Ther; 2013 Jun; 13(6):889-900. PubMed ID: 23441760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types.
    Ascierto PA; Kalos M; Schaer DA; Callahan MK; Wolchok JD
    Clin Cancer Res; 2013 Mar; 19(5):1009-20. PubMed ID: 23460532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy.
    Callahan MK; Wolchok JD
    J Leukoc Biol; 2013 Jul; 94(1):41-53. PubMed ID: 23667165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeted and immune-targeted monoclonal antibodies: Going from passive to active immunotherapy.
    Marabelle A; Gray J
    Pediatr Blood Cancer; 2015 Aug; 62(8):1317-25. PubMed ID: 25808079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of novel agents in the treatment of colorectal cancer.
    Iqbal S; Lenz HJ
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L
    Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 inhibition with MPDL3280A for solid tumors.
    Cha E; Wallin J; Kowanetz M
    Semin Oncol; 2015 Jun; 42(3):484-7. PubMed ID: 25965367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibodies for the Treatment of Cancer.
    Pento JT
    Anticancer Res; 2017 Nov; 37(11):5935-5939. PubMed ID: 29061772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Mateus C; Libenciuc C; Robert C
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S4-S11. PubMed ID: 27494973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Therapies in Cancer.
    Wang S; Jia M
    Adv Exp Med Biol; 2016; 909():1-67. PubMed ID: 27240456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
    Shapira S; Lisiansky V; Arber N; Kraus S
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies.
    Keung EZ; Wargo JA
    Surg Oncol Clin N Am; 2019 Jul; 28(3):369-386. PubMed ID: 31079794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.